2-129980618-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_032144.3(RAB6C):c.503G>A(p.Arg168Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000409 in 1,613,026 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032144.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAB6C | NM_032144.3 | c.503G>A | p.Arg168Gln | missense_variant | 1/1 | ENST00000410061.4 | NP_115520.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAB6C | ENST00000410061.4 | c.503G>A | p.Arg168Gln | missense_variant | 1/1 | NM_032144.3 | ENSP00000387307 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000172 AC: 26AN: 151384Hom.: 0 Cov.: 29
GnomAD3 exomes AF: 0.0000399 AC: 10AN: 250930Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135786
GnomAD4 exome AF: 0.0000274 AC: 40AN: 1461522Hom.: 0 Cov.: 32 AF XY: 0.0000261 AC XY: 19AN XY: 727064
GnomAD4 genome AF: 0.000172 AC: 26AN: 151504Hom.: 0 Cov.: 29 AF XY: 0.000176 AC XY: 13AN XY: 74012
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 16, 2022 | The c.503G>A (p.R168Q) alteration is located in exon 1 (coding exon 1) of the RAB6C gene. This alteration results from a G to A substitution at nucleotide position 503, causing the arginine (R) at amino acid position 168 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at